Loading…
Polaryx Therapeutics, Inc. is projected to decline to $2.10 by 2027, a -9% move from its current price of $2.32. PLYX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.18 | $2.32 | $2.46 | -0.04% |
| Jul 14 | $2.13 | $2.32 | $2.52 | -0.09% |
| Jul 15 | $2.09 | $2.32 | $2.57 | -0.13% |
| Jul 16 | $2.05 | $2.32 | $2.61 | -0.18% |
| Jul 17 | $2.02 | $2.31 | $2.65 | -0.22% |
| Jul 18 | $2.00 | $2.31 | $2.68 | -0.27% |
| Jul 19 | $1.97 | $2.31 | $2.71 | -0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.97 | $2.31 | $2.71 | -0.31% |
| Week 2 | $1.84 | $2.31 | $2.89 | -0.63% |
| Week 3 | $1.74 | $2.30 | $3.03 | -0.94% |
| Week 4 | $1.67 | $2.29 | $3.15 | -1.25% |
| Week 5 | $1.60 | $2.28 | $3.26 | -1.56% |
| Week 6 | $1.54 | $2.28 | $3.37 | -1.87% |
| Week 7 | $1.49 | $2.27 | $3.46 | -2.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable therapy; and PLX-400, a preclinical stage novel gene therapy candidate.
The company was founded in 2014 and is based in Paramus, New Jersey.
Polaryx Therapeutics, Inc. (PLYX) operates in the Healthcare sector. The stock is currently priced at $2.32 with a market cap of $115.64M and is ranked 4114 by market capitalization. Its current price and market position reflect a niche biotech focus with a small-cap profile.
A major floor 30.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.6% away) — a key level to hold.
The nearest ceiling, 40.9% above — a clean break opens room to run.
A major ceiling 235.8% above — clearing it would confirm fresh momentum.
Key PLYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.50 | Sell | $2.46 | Sell |
| MA 10 | $2.55 | Sell | $2.49 | Sell |
| MA 20 | $2.45 | Sell | $2.55 | Sell |
| MA 50 | $2.99 | Sell | $3.47 | Sell |
| MA 100 | $4.02 | Sell | $7.19 | Sell |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.19 | Neutral |
| Stoch RSI (14) | 20.75 | Neutral |
| CCI (20) | -69.46 | Neutral |
| Williams %R (14) | -96.00 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -3.32 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 4.00 | Buy |
| TRIX (15) | -0.92 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 36.43 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 2.41 | Sell |
| ADX (14) | 18.63 | Neutral |
| ATR (14) | 0.13 | Info |
The 30-day technical picture is neutral, with RSI(14) at 40 and the 50-day simple moving average listed at $2.99. The price sits between support and resistance, with support at $2.26 and resistance at $3.27. The 30-day range spans from a low of $1.56 to a high of $3.45, indicating notable volatility within a tight trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.26 | $2.32 | $3.25 | 0% | Neutral | |
| $1.37 | $2.10 | $3.48 | -9% | Neutral | |
| $1.05 | $1.78 | $3.21 | -23% | Bearish | |
| $0.9032 | $1.68 | $3.23 | -28% | Bearish | |
| $0.9285 | $1.89 | $3.82 | -19% | Bearish | |
| $1.16 | $2.55 | $5.40 | +10% | Neutral | |
| $1.17 | $2.60 | $5.72 | +12% | Neutral | |
| $1.12 | $2.49 | $5.67 | +7% | Neutral | |
| $1.16 | $2.57 | $5.90 | +11% | Neutral | |
| $0.9804 | $2.18 | $5.01 | -6% | Neutral | |
| $1.51 | $3.36 | $7.72 | +45% | Bullish | |
| $2.44 | $5.42 | $12.46 | +134% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.26 | $2.32 | $2.84 | +0.00% |
| August 2026 | $1.73 | $2.15 | $2.83 | -7.28% |
| September 2026 | $1.75 | $2.23 | $3.01 | +3.53% |
| October 2026 | $1.79 | $2.33 | $3.22 | +4.41% |
| November 2026 | $1.72 | $2.26 | $3.20 | -2.71% |
| December 2026 | $1.68 | $2.25 | $3.25 | -0.35% |
Click any year to see its month-by-month PLYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PLYX to range from $2.26 to $3.25 through 2026. The $2.32 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The PLYX price prediction for 2027 points to an average of $2.10 (low $1.37, high $3.48) — a potential decline of -9% on today's $2.32. A consolidation phase looks the most probable path here.
In 2028, PLYX is projected to trade between $1.05 and $3.21, averaging $1.78 — a potential decline of -23% from today's $2.32. That is -15% versus the projected 2027 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Polaryx Therapeutics, Inc.'s 2029 outlook centres on $1.68, within a $0.9032 to $3.23 range. That is -6% versus the projected 2028 average. That marks a -28% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2030, PLYX could reach as high as $3.82, with a base case around $1.89 and support toward $0.9285 — roughly -19% from $2.32. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect PLYX to range from $1.16 to $5.40 through 2031. The $2.55 average target implies a +10% move from current prices. That is up +35% on the projected 2030 average. A consolidation phase looks the most probable path here.
The PLYX price prediction for 2032 points to an average of $2.60 (low $1.17, high $5.72) — a potential gain of +12% on today's $2.32. Price action looks broadly range-bound.
In 2033, PLYX is projected to trade between $1.12 and $5.67, averaging $2.49 — a potential gain of +7% from today's $2.32. That is -4% versus the projected 2032 average. A consolidation phase looks the most probable path here.
Polaryx Therapeutics, Inc.'s 2034 outlook centres on $2.57, within a $1.16 to $5.90 range. That is up +3% on the projected 2033 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2035, PLYX could reach as high as $5.01, with a base case around $2.18 and support toward $0.9804 — roughly -6% from $2.32. A consolidation phase looks the most probable path here.
Expect PLYX to range from $1.51 to $7.72 through 2040. The $3.36 average target implies a +45% move from current prices. That is up +54% on the projected 2035 average. Momentum favours further upside here.
The PLYX price prediction for 2050 points to an average of $5.42 (low $2.44, high $12.46) — a potential gain of +134% on today's $2.32. Buyers look set to stay in control over this stretch.
Investing $1,000 in PLYX today (≈ 431.034483 PLYX) could be worth
$2,335.08
+$1,335.08 (+134%) by 2050 · US Dollar
Based on the average projected PLYX price of $5.42 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLYXwould be worth at today's price.
$1,000 invested in PLYX on Feb 2, 2026 (≈ 28.571429 PLYX) would be worth
$66.29
-$933.71 (-93.4%) today · 0.07× · US Dollar
Based on a PLYX entry price of $35 vs. today's $2.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.81 | $825.62 | -17.4% |
| 1 month ago | $2.26 | $1,026.55 | +2.7% |
| 3 months ago | $5.68 | $408.45 | -59.2% |
| All time ago | $35 | $66.29 | -93.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLYX forecast.
Our base-case forecast reaches $4.60 around 2050.
Implied market cap at $4.60: $229.29M
Longer-horizon forecasts show a mixed trajectory. For 2026, the average price is $2.32 with a min of $2.26 and a max of $3.25, and a neutral sentiment with 0% ROI. The following years reveal further declines in several years: 2027 average $2.10 (min $1.37, max $3.48, ROI -9.5, neutral); 2028 average $1.78 (min $1.05, max $3.21, ROI -23.3, bear); 2029 average $1.68 (min $0.9032, max $3.23, ROI -27.5, bear); 2030 average $1.89 (min $0.9285, max $3.82, ROI -18.7, bear).
Beginning 2031, the outlook improves with 2031 average $2.55 (min $1.16, max $5.40, ROI 10.1, neutral) and 2032 average $2.60 (min $1.17, max $5.72, ROI 12.1, neutral), followed by 2033 average $2.49 (min $1.12, max $5.67, ROI 7.5, neutral) and 2034 average $2.57 (min $1.16, max $5.90, ROI 10.7, neutral). 2035 shows a slight dip to average $2.18 (min $0.9804, max $5.01, ROI -6.1, neutral). The forecast turns bullish later, with 2040 average $3.36 (min $1.51, max $7.72, ROI 44.7, bullish) and 2050 average $5.42 (min $2.44, max $12.46, ROI 133.5, bullish).
The overarching narrative is a shift from earlier bearish years to stronger upside in the far horizon, albeit with substantial volatility and uncertainty.
Tap a question to reveal the answer.
2030 forecast: min $0.9285, avg $1.89, max $3.82 with ROI -18.7 and sentiment BEARISH.
Forecast shows mixed performance: early years are bearish with negative ROIs, but later years turn bullish (2040 avg $3.36 with 44.7 ROI and 2050 avg $5.42 with 133.5 ROI). These are estimates, not guarantees, and carry high uncertainty.
Yes. The forecast includes years with max values above $5: 2031 max $5.40, 2032 max $5.72, 2033 max $5.67, 2034 max $5.90, 2035 max $5.01, 2040 max $7.72, and 2050 max $12.46.
Current price is $2.32 and market cap is $115.64M. The 30-day range is from $1.56 to $3.45, and annualized volatility is 100, indicating high volatility.
RSI(14) is 40, with a support level at $2.26 and resistance at $3.27. The 50-day SMA is $2.99, placing the price near but below the longer-term moving average.
Polaryx Therapeutics, Inc. Community Discussion
0Share your Polaryx Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.